funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
United States
HQ address
Boston, USA
Email
info@alkeus.com
description
Stargardt disease is a genetic disease that causes improper transport of vitamin A in the eye and in the formation of toxic vitamin A aggregates responsible for vision loss. Stargardt disease is untreatable and irreversibly progresses to legal blindness. ALK-001 is Alkeus lead medication, undergoing clinical trials. ALK-001 is an oral medication. Please contact us at info@alkeus.com for more information.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats